These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16960635)

  • 1. A survey of the pain experienced by males and females with Fabry disease.
    Gibas AL; Klatt R; Johnson J; Clarke JT; Katz J
    Pain Res Manag; 2006; 11(3):185-92. PubMed ID: 16960635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy--a retrospective analysis from the Fabry Outcome Survey.
    Hoffmann B; Beck M; Sunder-Plassmann G; Borsini W; Ricci R; Mehta A;
    Clin J Pain; 2007; 23(6):535-42. PubMed ID: 17575495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Musculoskeletal manifestations of Fabry disease: A retrospective study.
    Lidove O; Zeller V; Chicheportiche V; Meyssonnier V; Sené T; Godot S; Ziza JM
    Joint Bone Spine; 2016 Jul; 83(4):421-6. PubMed ID: 26697993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease rarity, carrier status, and gender: a triple disadvantage for women with Fabry disease.
    Gibas AL; Klatt R; Johnson J; Clarke JT; Katz J
    J Genet Couns; 2008 Dec; 17(6):528-37. PubMed ID: 18931895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life.
    Wang RY; Lelis A; Mirocha J; Wilcox WR
    Genet Med; 2007 Jan; 9(1):34-45. PubMed ID: 17224688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabry disease and the skin: data from FOS, the Fabry outcome survey.
    Orteu CH; Jansen T; Lidove O; Jaussaud R; Hughes DA; Pintos-Morell G; Ramaswami U; Parini R; Sunder-Plassman G; Beck M; Mehta AB;
    Br J Dermatol; 2007 Aug; 157(2):331-7. PubMed ID: 17573884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry.
    Sims K; Politei J; Banikazemi M; Lee P
    Stroke; 2009 Mar; 40(3):788-94. PubMed ID: 19150871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of Fabry disease in females in the Fabry Outcome Survey.
    Deegan PB; Baehner AF; Barba Romero MA; Hughes DA; Kampmann C; Beck M;
    J Med Genet; 2006 Apr; 43(4):347-52. PubMed ID: 16227523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of pain in fabry disease.
    Üçeyler N; Ganendiran S; Kramer D; Sommer C
    Clin J Pain; 2014 Oct; 30(10):915-20. PubMed ID: 24121530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry.
    Eng CM; Fletcher J; Wilcox WR; Waldek S; Scott CR; Sillence DO; Breunig F; Charrow J; Germain DP; Nicholls K; Banikazemi M
    J Inherit Metab Dis; 2007 Apr; 30(2):184-92. PubMed ID: 17347915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of patients with Fabry disease in Argentina].
    AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales)
    Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-administered version of the Fabry-associated pain questionnaire for adult patients.
    Magg B; Riegler C; Wiedmann S; Heuschmann P; Sommer C; Üçeyler N
    Orphanet J Rare Dis; 2015 Sep; 10():113. PubMed ID: 26381732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive Fabry-related pain questionnaire for adult patients.
    Üçeyler N; Magg B; Thomas P; Wiedmann S; Heuschmann P; Sommer C
    Pain; 2014 Nov; 155(11):2301-5. PubMed ID: 25168668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy.
    Ortiz A; Oliveira JP; Waldek S; Warnock DG; Cianciaruso B; Wanner C;
    Nephrol Dial Transplant; 2008 May; 23(5):1600-7. PubMed ID: 18175781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographic characterization of Brazilian patients enrolled in the Fabry Registry.
    Martins AM; Kyosen SO; Garrote J; Marques FM; Guilhem JG; Macedo E; Sobral Neto J; Ura S
    Genet Mol Res; 2013 Jan; 12(1):136-42. PubMed ID: 23408399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey.
    Sodi A; Ioannidis AS; Mehta A; Davey C; Beck M; Pitz S
    Br J Ophthalmol; 2007 Feb; 91(2):210-4. PubMed ID: 16973664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and structural nerve fiber findings in heterozygote patients with Fabry disease.
    Torvin Møller A; Winther Bach F; Feldt-Rasmussen U; Rasmussen A; Hasholt L; Lan H; Sommer C; Kølvraa S; Ballegaard M; Staehelin Jensen T
    Pain; 2009 Sep; 145(1-2):237-45. PubMed ID: 19665302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry.
    Ortiz A; Cianciaruso B; Cizmarik M; Germain DP; Mignani R; Oliveira JP; Villalobos J; Vujkovac B; Waldek S; Wanner C; Warnock DG
    Nephrol Dial Transplant; 2010 Mar; 25(3):769-75. PubMed ID: 19846394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents.
    Ries M; Ramaswami U; Parini R; Lindblad B; Whybra C; Willers I; Gal A; Beck M
    Eur J Pediatr; 2003 Nov; 162(11):767-72. PubMed ID: 14505049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabry disease in children: a federal screening programme in Russia.
    Namazova-Baranova LS; Baranov AA; Pushkov AA; Savostyanov KV
    Eur J Pediatr; 2017 Oct; 176(10):1385-1391. PubMed ID: 28871487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.